Paraneoplastic syndrome is a rare and poorly understood systemic manifestation of malignancy that can involve multiple organ systems. [1] Detection of the underlying malignancy is key to treatment.

Dr. Ticiana Leal from Emory University's Winship Cancer Institute and Dr. Wade Iams from Tennessee Oncology introduce their ...

Please provide your email address to receive an email when new articles are posted on . In this Healio Video Perspective from the Retina Society meeting, Carol Shields, MD, describes an interesting ...

Prediction of pathologic complete response to neoadjuvant chemotherapy in urothelial cancer by genetic determinants of platinum sensitivity. This is an ASCO Meeting Abstract from the 2013 ...

The Paraneoplastic Syndrome Treatment Market is undergoing significant transformations, influenced heavily by its interconnectedness with various end-use industries. These industries are pivotal in ...

Paraneoplastic syndromes are groups of certain signs and symptoms that develop in some people with cancer. The name comes from the word “para” which means “alongside of,” and “neoplasm,” which means ...

Pembrolizumab in patients with recurrent thymic carcinoma: Results of a phase II study. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does not include a full text ...

RENAL CELL CARCINOMA IS CHARACTERIZED by varied manifestations, which include unusual metastatic sites and paraneoplastic and vascular syndromes. We describe the case of a 57-year-old man who ...

Timely intervention led to a recovery in rare diseases. A 43-year-old housewife in South Suburban Kolkata experienced stroke-like symptoms linked to breast cancer. Doctors discovered Paraneoplastic ...